Charles River Laboratories International formally opened its 60,000 square foot preclinical facility in Shanghai. The international CRO and Shanghai BioExplorer formed a JV called Charles River Preclinical Services Greater China, which owns and runs the facility, with Charles River being the majority partner. Dr. Kewin Jin will serve as General Manager of Charles River Shanghai. Jin, one of the quintessential sea turtles, is a co-founder of Shanghai BioExplorer.  More details...

Stock Symbols: (NYSE: CRL) ( NYSE: WYE)